deferasirox synthon hispania 360 mg, filmomhulde tabletten
synthon hispania s.l. castelló 1, polígono las salinas 08830 sant boi de llobregat (spanje) - deferasirox 360 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; glyceroltriacetaat (e 1518) ; hypromellose (e 464) ; indigokarmijn aluminiumlak (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; poloxameer 188 ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; titaandioxide (e 171) - deferasirox
deferasirox synthon hispania 90 mg, filmomhulde tabletten
synthon hispania s.l. castelló 1, polígono las salinas 08830 sant boi de llobregat (spanje) - deferasirox 90 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; glyceroltriacetaat (e 1518) ; hypromellose (e 464) ; indigokarmijn aluminiumlak (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; poloxameer 188 ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; titaandioxide (e 171) - deferasirox
lacosamide krka 100 mg filmomh. tabl.
krka d.d. novo mesto d.d. - lacosamide 100 mg - filmomhulde tablet - 100 mg - lacosamide 100 mg - lacosamide
lacosamide krka 150 mg filmomh. tabl.
krka d.d. novo mesto d.d. - lacosamide 150 mg - filmomhulde tablet - 150 mg - lacosamide 150 mg - lacosamide
lacosamide krka 200 mg filmomh. tabl.
krka d.d. novo mesto d.d. - lacosamide 200 mg - filmomhulde tablet - 200 mg - lacosamide 200 mg - lacosamide
lacosamide krka 50 mg filmomh. tabl.
krka d.d. novo mesto d.d. - lacosamide 50 mg - filmomhulde tablet - 50 mg - lacosamide 50 mg - lacosamide
entresto
novartis europharm limited - sacubitril, valsartan - hartfalen - angiotensine ii-antagonisten, andere combinaties van geneesmiddelen die op het renine-angiotensine systeem - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
neparvis
novartis europharm limited - sacubitril, valsartan - hartfalen - middelen die werken op het renine-angiotensinesysteem - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
rosuvastatin/valsartan hcs 10 mg - 80 mg filmomh. tabl.
hcs s.p.r.l.-b.v.b.a. - valsartan 80 mg; rosuvastatinecalcium 10,42 mg - eq. rosuvastatine 10 mg - filmomhulde tablet - 10 mg - 80 mg - rosuvastatinecalcium 10.42 mg; valsartan 80 mg - rosuvastatin and valsartan
rosuvastatin/valsartan hcs 10 mg - 160 mg filmomh. tabl.
hcs s.p.r.l.-b.v.b.a. - valsartan 160 mg; rosuvastatinecalcium 10,42 mg - eq. rosuvastatine 10 mg - filmomhulde tablet - 10 mg - 160 mg - rosuvastatinecalcium 10.42 mg; valsartan 160 mg - rosuvastatin and valsartan